Atalanta Sosnoff Capital LLC Sells 57,790 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Atalanta Sosnoff Capital LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,259 shares of the healthcare conglomerate's stock after selling 57,790 shares during the period. Atalanta Sosnoff Capital LLC's holdings in UnitedHealth Group were worth $45,658,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $30,000. Finally, AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at about $30,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.5 %

Shares of NYSE UNH traded down $1.96 during mid-day trading on Friday, reaching $398.72. 11,384,114 shares of the company traded hands, compared to its average volume of 4,611,075. The stock has a market cap of $362.92 billion, a PE ratio of 25.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company's fifty day moving average is $495.85 and its two-hundred day moving average is $528.18. UnitedHealth Group Incorporated has a fifty-two week low of $393.11 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the business posted $6.91 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is currently 35.18%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research analyst reports. Hsbc Global Res lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 22nd. HSBC reiterated a "hold" rating and issued a $490.00 price target on shares of UnitedHealth Group in a research note on Tuesday, April 22nd. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. KeyCorp lowered their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Finally, Morgan Stanley decreased their price target on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $596.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.